Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 8-K Event Material agreement · New debt or obligation · Executive or director change · Shareholder vote results
  2. 4 Insider Changes in Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4/A Insider Changes in Ownership
  12. 4/A Insider Changes in Ownership
  13. 4/A Insider Changes in Ownership
  14. DEFA14A Proxy Proxy Materials
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 24 · 467 filings